DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Carving Out a Share of the Robotic Surgery Market: The US Perspective

 

Robotic surgery has established a significant presence in today’s operating rooms and will become increasingly intertwined with the operating rooms of tomorrow. Medical device companies can ill afford
to remain on the sidelines and adopt a passive attitude. They must seize the opportunity to engage more actively and positively with robotic surgery, whether through developing new robotic platforms or designing tools for existing platforms. That being said, certain considerations must be taken before going down this path. In particular, understanding the current procedural landscape, identifying limitations of the incumbent robotic system, and focusing on clinical and economic value can all help companies capitalize on the growing robotic surgery market.